Johnson & Johnson has announced another recall of nearly 47 million packages of Sudafed, Tylenol, Rolaids tablets, and other nonprescription drugs manufactured at a Pennsylvania facility. The plant was shut down this past April after FDA inspectors discovered a number of violations related to a lack of cleanliness.
The company says that consumers who have the products already can continue using them, but cautions wholesalers to pull the medications from shelves. After an internal review of manufacturing practices at the Pennsylvania facility, J & J determined that certain manufacturing processes had not been followed and certain labeling information required by regulations was not included. When inspectors toured the facility, they found equipment covered with dust and held together with duct tape.
For all of the products recalled go to: http://www.mcneilproductrecall.com/index.jhtml
$3.5 Million Settlement
Defective Product
